<DOC>
	<DOCNO>NCT01884909</DOCNO>
	<brief_summary>This open Label , randomize , two-period , two-treatment , two-sequence , crossover , balance , single dose pivotal study . The purpose study assess bioequivalence Test Product correspond Reference Product fed condition healthy adult human subject .</brief_summary>
	<brief_title>Bioequivalence Study Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions</brief_title>
	<detailed_description>Objective pivotal study assess bioequivalence Test Product : Metoprolol Succinate 200 mg Ipca Laboratories Limited , India correspond Reference Product : TOPROL-XL® ( Metoprolol Succinate ) extend release Tablets 200 mg Astrazenica LP , USA fed condition healthy adult human subject randomize crossover study . The study conduct 48 healthy adult subject . In study period , single 200 mg dose either test reference administer subject per randomization schedule study period 240 mL water ambient temperature sit position . The duration clinical phase approximately 11 day include washout period least 7 day administration study drug study period .</detailed_description>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>1 . 18 45 year old , inclusive . 2 . Sex : Males and/or nonpregnant , nonlactating female . 3 . BMI : 18.5 24.9 weight kg/ ( height meter ) 2 inclusive ; 4 . Able communicate effectively study personnel willingness follow protocol requirement evidence write informed consent . 5 . Able give write informed consent participate study . 6 . All volunteer must judge principal coinvestigator physician normal healthy prestudy safety assessment perform within 21 day first dose study medication include : A physical examination clinically significant finding . Results within normal limit clinically nonsignificant test mention List Laboratory Parameters : Additional test and/or examination may perform , necessary , base Principal Investigator discretion . All result assess laboratory normal range current time test copy normal range use include study documentation . 1 . History allergic response Metoprolol Succinate relate drug , formulation ingredient . 2 . Have significant disease clinically significant abnormal finding screen , [ medical history , physical examination , laboratory evaluation , ECG , chest Xray recording , obstetrics gynecological history examination along PAP smear ( female volunteer ) &amp; transvaginal ultrasonography ( female volunteer ) ] . 3 . Any disease condition might compromise haemopoeitic , gastrointestinal , renal , hepatic , cardiovascular , respiratory , central nervous system , diabetes , psychosis body system . 4 . History presence bronchial asthma . 5 . Use hormone replacement therapy within 3 month prior study medication dosing . 6 . A depot injection implant drug within 3 month prior administration study medication . 7 . Use enzymemodifying drug within 30 day prior receive first dose study medication . 8 . History evidence drug dependence alcoholism moderate alcohol use . 9 . Smokers smoke 10 cigarette per day 20 biddy per day refrain smoke study period . 10 . History difficulty donate blood difficulty accessibility vein . 11 . History allergic response heparin . 12 . A positive hepatitis screen ( include subtypes B &amp; C ) . 13 . A positive test result HIV antibody / syphilis ( RPR/VDRL ) . 14 . Volunteers donate blood ( 1 unit 450 mL ) within 90 day prior initial dose study drug blood loss , exclude volume drawn screen study , ( ≤100 mL within 30 day ; ≤200 mL within 60 day ; &gt; 200 mL within 90 day ) prior initial dose study drug . 15 . History difficulty swallowing , gastrointestinal disease could affect drug absorption . 16 . Intolerance venipuncture 17 . Any food allergy , intolerance , restriction special diet , opinion Principal Investigator CoInvestigator , could contraindicate volunteer 's participation study . 18 . Volunteers receive known investigational drug within five elimination half life administer drug prior initial dose study drug participate clinical drug study bioequivalence study within 90 day prior initial dose study drug , whichever great . 19 . Found positive urine test drug abuse do checkin period I .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>